Alprazolam lingual spray

Drug Profile

Alprazolam lingual spray

Latest Information Update: 11 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NovaDel Pharma
  • Class Anxiolytics; Benzodiazepines; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders

Most Recent Events

  • 11 Feb 2008 Discontinued - Preclinical for Anxiety disorders in USA (Transmucosal)
  • 02 May 2005 Clinical data from a media release have been added to the pharmacokinetics section
  • 26 Feb 2004 Preclinical trials in Anxiety disorders in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top